InnoTek Limited Announces S\$16 Million Share Placement and CEO Share Sale

Key Highlights

• Proposed Placement: Up to 24.6 million new shares at S\$0.6506 per share, raising approximately S\$16 million.
• Vendor Share Sale: CEO Lou Yiliang to sell 6.15 million shares at S\$0.6506 per share after the placement, with a voluntary 6-month moratorium on further sales.
• Placement Price: Represents a 9.5% discount to the last volume-weighted average price of S\$0.7189 per share.
• Proceeds Use: Funds earmarked for acquisitions, joint ventures, strategic alliances, Southeast Asia expansion, and working capital.
• Financial Impact: Placement will increase share base by 10.6% and expand the free float, with slight dilution to EPS and NTA per share.
• Shareholder Relevance: No controlling interest change. Placement is not open to directors, substantial shareholders, or interested persons (unless exempted).
• SGX-ST Approval Needed: Placement is subject to regulatory clearances and market conditions.

Detailed Announcement

InnoTek Limited has entered into a Placement Agreement with Maybank Securities Pte. Ltd. to issue up to 24,600,372 new ordinary shares at a placement price of S\$0.6506 per share. This will raise gross proceeds of approximately S\$16.0 million. The placement is on a best-efforts basis and not underwritten. The Placement Agent receives a 3% commission on the aggregate placement value, but all brokerage fees are paid by subscribers, not the company.

Structure and Rationale

• The Placement Price is at a 9.5% discount to the last traded VWAP of S\$0.7189, reflecting the company’s aim to attract new institutional and accredited investors while accounting for market conditions.
• The Placement Shares will comprise approximately 10.55% of the company’s existing issued and paid-up capital and about 9.54% post-placement.
• Placement Shares will be entitled to the recommended final FY2025 dividend of S\$0.02 per share, provided they are issued before the dividend record date.
• No Placement Shares will be offered to directors, substantial shareholders, or interested persons (unless exempted), ensuring compliance with SGX Listing Manual rules and preventing any change in controlling interest.

Regulatory and Execution Details

• The placement is conducted under SFA exemptions and no prospectus will be lodged with SGX or MAS.
• Completion is expected within three business days of SGX-ST’s approval for listing and quotation of the new shares, no later than three weeks from the agreement date unless extended by mutual consent.
• A 90-day moratorium is imposed on further issuance of shares by the company except as required by law, employee share schemes, or dividend reinvestment.

Use of Proceeds

The company will provide updates on the use of proceeds in interim and full-year results, and announce any material reallocation or deviation.

Financial Effects

• Share Capital: Enlarged from 233.3 million to 257.9 million shares.
• EPS (Based on FY2024): Diluted from 2.49 S cents to 2.25 S cents.
• NTA per share: Slightly reduced from 75.52 S cents to 74.31 S cents.
• NTA (absolute): Increased from S\$176.2 million to S\$191.6 million.

Vendor Share Sale by CEO Lou Yiliang

• Mr. Lou Yiliang, CEO and Executive Director, will sell up to 6,150,000 shares at S\$0.6506 per share by a married deal, two trading days after the placement shares are listed.
• Post-sale, Mr. Lou will retain a direct and deemed interest in 9.63% of the enlarged share capital and has committed to a voluntary 6-month moratorium on further disposals, signaling his confidence in the business’s long-term prospects.
• This sale is intended for personal wealth and retirement planning, and will not result in any dilution to existing shareholders as these are secondary shares.
• The Vendor Share Sale is expected to broaden the investor base and improve share liquidity.

What Shareholders Should Note

• Potential Price Impact: The placement and CEO’s share sale are significant, price-sensitive events. The discounted placement price may influence the market price. Investors should also note the short-term dilution impact on EPS and NTA per share.
• Improved Liquidity: Both the placement and vendor sale will expand the free float and diversify the shareholder base, potentially enhancing liquidity.
• No Change in Control: No transfer of controlling interest. Directors and substantial shareholders are excluded from the placement (unless exempted).
• Moratoriums: Company is restricted from issuing further shares for 90 days post-placement, and CEO is restricted from selling more shares for 6 months post-sale.
• Completion Risks: Both the placement and vendor share sale are subject to regulatory and market conditions. There is no certainty of their completion.

Conclusion

The proposed S\$16 million placement and CEO’s share sale are major corporate actions for InnoTek Limited. They will strengthen the company’s financial flexibility for growth, broaden the investor base, and potentially enhance liquidity. However, investors should take note of the share price discount, short-term dilution, and the successful execution risks.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors are advised to read official company announcements and consult their professional advisers before making any investment decisions. There is no assurance that the placement or vendor share sale will be completed, and shareholders should exercise caution when dealing in the company’s securities.

View InnoTek Historical chart here